Prospective Study
Copyright ©The Author(s) 2020.
World J Orthop. May 18, 2020; 11(5): 265-277
Published online May 18, 2020. doi: 10.5312/wjo.v11.i5.265
Table 3 Outcome measures for 3 time points pre-op (T1), post-operative (4-8 wk) (T2), and post-operative (9-14 mo) (T3)
nMeanSDMean rankP
T2 vs T11T3 vs T11T3 vs T21Overall2
VAST11337.641.992.71000.020.05
T21034.812.611.93
T3524.023.441.36
EQ5DT11290.590.1931.590.3800.020.05
T21030.670.2041.91
T3540.740.2292.5
EQ5D-VAST113169.3120.4351.710.660.010.20.05
T210575.5217.041.96
T3547617.12.33
KOOS-painT113037.318.531.30.01000.05
T21045619.511.91
T35470.8725.382.79
KOOS-symptomT113040.6415.711.27000.070.05
T210555.1914.592.14
T35661.5418.222.59
KOOS-ADLT112942.2220.971.32000.010.05
T210564.4221.292.04
T35470.726.312.64
KOOS-sportT113038.6137.91.510.0500.050.05
T210355.1641.112
T35562.2937.322.49
KOOS-QOLT113017.1718.991.34000.010.05
T210434.3119.952.02
T35547.2930.932.64